ASH 2018 | Mass spectrometry-flow cytometry study of IgM MGUS progression to Waldenström’s
VJHemOnc is committed to improving our service to you
Thanks for your feedback, this will help us improve our content for you!
Immunoglobulin M monoclonal gammopathy of undetermined significance (IgM MGUS), a relatively common condition, may progress to Waldenström’s Macroglobulinemia (WM). Speaking from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, Jonas Paludo, MD, of the Mayo Clinic, Rochester, MN, discusses the immune system profiling of WM and IgM MGUS using CyTOF mass spectrometry, a novel platform coupling mass spectrometry with single-cell flow cytometry using antibody-metal isotope pairs.
Get great new content delivered to your inboxSign up
VOD: treatment and prevention
Targeting T-cell malignancies with CRISPR/Cas9 gene edited universal CAR-T
Relative dose intensity in older DLBCL patients
Benefits of rituximab for elderly DLBCL patients
Comparing geriatric screening methods in elderly NHL patients
More from Jonas Paludo